期刊文献+

乳杆菌抑制金黄色葡萄球菌对HeLa细胞的粘附 被引量:3

Lactobacillus inhibit adhesion of Staphylococcus aureus to HeLa cells
原文传递
导出
摘要 对弯曲乳杆菌Lactobacillus crispatus T79-3和T90-1、詹氏乳杆菌Lactobacillus jensenii T118-3和T231-1四株乳杆菌对金黄色葡萄球菌生长的抑制效果以及抑菌成分进行了分析,比较乳杆菌排除、竞争、置换3种不同作用方式对金黄色葡萄球菌粘附HeLa细胞的抑制作用。结果表明4株乳杆菌皆能抑制金黄色葡萄球菌的生长及其粘附HeLa细胞的能力,分析发现4株乳杆菌发挥抑制作用的主要成分是有机酸,同时比较分析乳杆菌3种不同作用方式发现它们对金黄色葡萄球菌粘附HeLa细胞的抑制效果不同,其中,排除作用方式效果最好。另外,乳杆菌对金黄色葡萄球菌粘附HeLa细胞的抑制作用具有浓度依赖性,随着乳杆菌浓度增大,抑制作用增强并逐渐达到饱和。4株乳杆菌中,T79-3粘附能力最强,对金黄色葡萄球菌的抑制作用最强,排除作用方式抑制金黄色葡萄球菌粘附HeLa细胞作用效果较好,提示乳杆菌T79-3有可能作为益生菌防治妇女泌尿生殖道感染。 To assess the ability of the previously selected human vaginal isolates of Lactobacillus crispatus (L. crispatus) T79-3, T90-1 and Lactobacillus jensenii (L. jensenii) T118-3, T231-1 to inhibit the growth of Staphylococcus aureus and block their adhesion to HeLa cells. The inhibitory bioactive substances produced by these Lactobacillus were also identified. Inhibitory substances interaction tests were carried out by using a streak-diffusion method on agar plates. Three types of interaction were performed to determine the inhibitory effect of Lactobacillus on adhesion of Staphylococcus aureus to HeLa cells: Exclusion Group (Lactobacillus and HeLa followed by pathogens), Competition Group (Lactobacillus, HeLa and pathogens together) and Displacement Group (pathogens and HeLa followed by the addition of Lactobacillus). The number of HeLa cells adhered to Staphylococcus aureus was quantified by bacteria colony counts on LB plate. The results showed that lactic acids produced by the Lactobacillus are the main substances that can inhibit Staphylococcus aureus growth and there is variation among the three types of interaction regarding the inhibitory activity against Staphylococcus aureus. The effects of Lactobacillus on blocking the adhesion to HeLa cells were concentration dependent. All four Lactobacillus isolates displayed the ability to inhibit Staphylococcus aureus growth and block Staphylococcus aureus adherence to HeLa cells. Exclusion Group was the most effective, and T79-3 showed greater capacity to block Staphylococcus aureus adherence compared with the other three isolates. The present study suggests the potential ability ofL. crispatus T79-3 as probiotic for the treatment and prevention of urogenital infections in women.
出处 《生物工程学报》 CAS CSCD 北大核心 2012年第6期715-725,共11页 Chinese Journal of Biotechnology
基金 国家重点基础研究发展计划(973计划)(No.2007CB513002) 北京市科技计划(No.D09050703570906) 浙江大学医学院第一附属医院传染病诊治国家重点实验室开放基金(No.2009KF12)资助~~
关键词 乳杆菌 金黄色葡萄球菌 粘附 HELA细胞 Lactobacillus, Staphylococcus aureus, adhesion, HeLa cell
  • 相关文献

参考文献26

  • 1Zarate G, Santos V, Nader-Macias ME. Protective effect of vaginal Lactobacillus paracasei CRL 1289 against urogenital infection produced by Staphylococcus aureus in a mouse animal model. Infect Dis Obstet Gynecol, 2007, 2007:48358-48363.
  • 2Baba-Moussa L, Anani L, Scheftel JM, et al. Virulence factors produced by strains of Staphylococcus aureus isolated from urinary tract infections. J Hosp Infect, 2008, 68: 32-38.
  • 3Reid G, Burton J, Hammond JA, et al. Nucleic acid-based diagnosis of bacterial vaginosis and improved management using probiotic Lactobacilli. J Med Food, 2004, 7: 223-228.
  • 4Lowy FD. Staphylococcus aureus infections. N Engl J Med, 1998, 339(8): 520-532.
  • 5Musser JM, Schlievert. PM, Chow. AW, et al. A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc Natl Acad Sci USA, 1990, 87(1):225-229.
  • 6Pavlova SI, Kilic AO, Kilic SS, et al. Genetic diversity of vaginal lactobacilli from women in different countries based on 16S rRNA gene sequences. J Appl Microbiol, 2002, 92(3): 451-459.
  • 7Matu MN, Orinda GO, Njagi ENM, et al. In vitro inhibitory activity of human vaginal Lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women. Anaerobe, 2010, 16(3): 210-215.
  • 8Klebanoff MA, Schwebke JR, Zhang J, et al. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol, 2004, 104(2): 267-272.
  • 9Reid G, Burton J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect, 2002, 4(3): 319-324.
  • 10Abad CL, Safdar N. The role of Laetobacillus probiotics in the treatment or prevention of urogenital infections-a systematic review. J Chemotherapy, 2009, 21(3): 243-252.

二级参考文献3

共引文献2

同被引文献31

  • 1肖越红,唐立,文姝,李武伟.乳杆菌DM9811代谢产物脂肪酸组分对义齿性口炎患者口腔中白假丝酵母菌的抑制[J].中国微生态学杂志,2006,18(1):35-36. 被引量:2
  • 2张筠,刘宁,孟祥晨.保加利亚乳杆菌胞外多糖对人癌细胞抑制作用的研究[J].中华预防医学杂志,2007,41(3):238-239. 被引量:7
  • 3张震康,俞光岩.口腔颌面外科[M].北京:北京大学医学出版社,2007.407-410.
  • 4李德舜,李鹏,王臻,苏静.杨树菇抑菌活性提取物理化性质的初步研究[J].山东大学学报(理学版),2007,42(9):7-10. 被引量:9
  • 5Chopra I, Roberts M. Tetracycline antibiotics, mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiology and molecular biology reviews, 2001,65 (2) : 232-238.
  • 6Castillo U F, Strobel G A, Ford E J, et al. Munumbicins, wide- spectrum antibiotics produced by Streptomyces NRRL 30562, endophytic on Kennedia nigriscans. Microbiol, 2002, 148 (9) : 2675 -2685.
  • 7Lisova Z A, Lisov A V, Leontievsky A A. Two laccase isoforms of the basidiomycete Cerrena unicolor VKMF-3196. Induction, isolation and properties. J Basic Microbiol, 2010, 50: 72-82.
  • 8Lyashenko A V, Zhukhlistova N E, Gabdoulkhakov A G, et al. Purification, crystallization and preliminary X-ray study of the fungal laccase from Cerrena maxima. Acta Crystallographica Section F: Structural Biology and Crystallization Communications, 2006, 62(10) : 954-957.
  • 9Songulashvili G, Jimenez-Tobon G A, Jaspers C, et al. Immobilized laecase of Cerrena unicolor for elimination of endocrine disruptor micropollutants. Fungal Biology, 2012, 116 (8) : 883-889.
  • 10Hidayat A, Tachibana S. Degradation of 2, 4, 8- trichlorodibenzofuran by a new isolate of Cerrena sp. F0607. International Biodetefioration & Biodegradation, 2013, 77 : 51-55.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部